Navigation Links
Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors
Date:6/2/2010

s or implied discussions regarding potential new indications or labeling for Afinitor or regarding potential future revenues from Afinitor. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results with Afinitor to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that Afinitor will be approved for any additional indications or labeling in any market. Nor can there be any guarantee that Afinitor will achieve any particular levels of revenue in the future. In particular, management's expectations regarding Afinitor could be affected by, among other things, unexpected clinical trial results, including unexpected new clinical data and unexpected additional analysis of existing clinical data; unexpected regulatory actions or delays or government regulation generally; the company's ability to obtain or maintain patent or other proprietary intellectual property protection; competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or
'/>"/>
SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
4. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
5. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
6. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
7. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
8. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
9. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
10. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
11. Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... ROCKVILLE, Md. , July 29, 2014  Synthetic ... anti-infective biologic and drug candidates targeting specific pathogens that ... view of the unusual market activity in the Company,s ... Company in accordance with its usual practice. The Company ... unusual market activity. About Synthetic Biologics, Inc. ...
(Date:7/29/2014)... According to a new market ... Market (Neurosurgical Navigation Systems, ENT Navigation Systems and Orthopedic ... Trends and Forecast, 2014 - 2020", the global surgical ... in 2013 and is expected to grow at a ... an estimated value of USD 295.5 million in 2020. ...
(Date:7/29/2014)... , July, 29  2014 ISPE—the International Society ... John Bournas as President and CEO, ... to leave the Society last fall.  Mr. Bournas ... in the healthcare association industry as well as ... a clear vision for the expansion of its ...
Breaking Medicine Technology:Synthetic Biologics, Inc. States that Its Policy is Not to Comment on Unusual Market Activity 2Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 2Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 3Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 4ISPE Hires Healthcare Association Exec as CEO 2ISPE Hires Healthcare Association Exec as CEO 3
... Ill. , March 14 NorthShore University HealthSystem (NorthShore) ... the American College of Cardiology annual scientific sessions from the EVEREST ... novel, first-in-class catheter-based device,  is a safe and effective alternative to ... ...
... March 12 HEI, Inc. (Pink Sheets: HEII) ... has achieved qualification to MIL-P-50884E.  This qualification was awarded ... Agency.  DSCC manages Military qualifications for the electronics industry. ... Tempe, Arizona to manufacture rigid-flex and flex ...
Cached Medicine Technology:Minimally Invasive Heart Valve Therapy Improves Heart Function, Quality of Life for Mitral Regurgitation Patients 2Minimally Invasive Heart Valve Therapy Improves Heart Function, Quality of Life for Mitral Regurgitation Patients 3Minimally Invasive Heart Valve Therapy Improves Heart Function, Quality of Life for Mitral Regurgitation Patients 4HEI, Inc. Announces Qualification to MIL-P-50884E 2
(Date:7/29/2014)... 2014 CarePoint Health is proud ... our network, CarePoint Health Medical Group. Our system ... Hundreds of highly skilled and experienced physicians comprise ... top doctors and practices in Hudson County, representing ... represents CarePoint Health’s commitment to provide the highest ...
(Date:7/29/2014)... July 29, 2014 Many people complain about ... they do each morning is put on glasses to see ... These same individuals also may be dissatisfied with their vision ... , Cataracts may cause difficulty driving, especially at night due ... or find one’s golf ball, see the TV, sew or ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Tylenol ... individuals who allegedly suffered serious liver injuries due ... move forward in a multidistrict litigation underway in ... Liebhard LLP reports. According to an Order dated ... deadlines pertaining to bellwether case and discovery issues. ...
(Date:7/29/2014)... 2014 New high priced hepatitis C ... by a projected $2.9 to $5.8 billion next year, ... Milliman released today by the Pharmaceutical Care Management Association ... increase by as much as 8.6 percent in 2015 ... Sovaldi and Olysio. , The study finds that the ...
(Date:7/29/2014)... Historically, Memorial Day kicks off a ... celebrated throughout that time by picnics, barbecues and beach ... mark the start of a period that will witness ... In 2012 nearly 1.000 people were killed in crashes ... to Labor Day. , The summer's warmer weather, longer ...
Breaking Medicine News(10 mins):Health News:Dr. Politis and Dr. Kaki Join CarePoint Health Medical Group 2Health News:Dr. Politis and Dr. Kaki Join CarePoint Health Medical Group 3Health News:Cataract Surgery: New Technology for Reduced Dependence on Glasses 2Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 2Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 3Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 4Health News:New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015 2Health News:Narconon New Life Retreat Launches New Alcohol Prevention Program 2
... NORCROSS, Ga., Aug. 12 With the Centers for Disease ... of serious illnesses in school-age children (ages 5-24) and pregnant women ... can kill the virus immediately and continue to kill it for ... getting swine flu or avoiding it, especially before a vaccine is ...
... MINNEAPOLIS, Aug. 12 Twin Cities Orthopedics ... today announced a partnership with Surgical Care Affiliates (SCA) to develop ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080812/CLTU111LOGO ) , , ... be located at 4010 65th Street West Edina, Minnesota. In ...
... , , SAN ... in the field of remote patient monitoring, today announced that ... versions of the BlackBerry(R) Bold(TM), Tour(TM), Curve(TM) and 8800 ... for release this fall. , , ...
... , KENSINGTON, Md., Aug. 12 The ... a two-track contest united by a theme of helping psoriasis ... videos that will motivate psoriasis patients to resist the social ... and to engage with others with psoriasis and psoriatic arthritis ...
... cells, forcing remission, study says, , WEDNESDAY, Aug. ... suppresses the immune system to put multiple sclerosis ... Canadian scientists say. , In MS, the immune ... treatment, called GIFT15, is composed of two proteins, ...
... French . , Montreal, August 12, 2009 Sounds and ... to a new Canadian study. In the online edition of the ... ), scientists from the Universit de Montral and the Montreal Neurological ... the brain allows people to distinguish between different types of sounds, ...
Cached Medicine News:Health News:School-Age Children, Pregnant Women and Health Care Workers: Take Swine Flu Precautions by Washing with Cleanser that Kills Virus for Up to Six Hours 2Health News:School-Age Children, Pregnant Women and Health Care Workers: Take Swine Flu Precautions by Washing with Cleanser that Kills Virus for Up to Six Hours 3Health News:School-Age Children, Pregnant Women and Health Care Workers: Take Swine Flu Precautions by Washing with Cleanser that Kills Virus for Up to Six Hours 4Health News:Twin Cities Orthopedics to Partner with Surgical Care Affiliates 2Health News:AirStrip Technologies Releases AirStrip OB for BlackBerry 2Health News:AirStrip Technologies Releases AirStrip OB for BlackBerry 3Health News:Psoriasis Video Contest Launched to Encourage Psoriasis Patients to Connect and Collaborate 2Health News:Scientists Reverse Multiple Sclerosis in Mice 2Health News:Human mind: Sound and vision wired through same 'black box' 2
... enclosures are designed for ... other process gas to ... HEPA filtration, heating/cooling, humidification, ... also available, along with ...
... removes chemical fumes, allowing safe ... charcoal filters remove most organic ... exhaust flow speed = 100 ... Includes air speed monitor, quick-release ...
This free-standing work station safely ventilates fumes upwards, away from the work surface. Optional Exhaust Purification System features bonded charcoal filters that remove organic chemical vapors ...
... These corrosion proof polypropylene exhaust hoods are ... of tanks and draw a stream of ... away from the operator. Other sizes and ... lateral, and double-slot are available on special ...
Medicine Products: